https://scholars.lib.ntu.edu.tw/handle/123456789/551886
標題: | Edoxaban versus warfarin in patients with atrial fibrillation | 作者: | Giugliano, Robert P Ruff, Christian T Braunwald, Eugene Murphy, Sabina A Wiviott, Stephen D Halperin, Jonathan L Waldo, Albert L Ezekowitz, Michael D Weitz, Jeffrey I Špinar, Jindřich Ruzyllo, Witold Ruda, Mikhail Koretsune, Yukihiro Betcher, Joshua Shi, Minggao Grip, Laura T Patel, Shirali P Patel, Indravadan Hanyok, James J Mercuri, Michele Antman, Elliott M FU-TIEN CHIANG |
關鍵字: | FACTOR XA INHIBITOR; ORAL ANTICOAGULANTS; STROKE; PHARMACOKINETICS; METAANALYSIS; GENERATION; PREVENTION; SAFETY | 公開日期: | 28-十一月-2013 | 出版社: | MASSACHUSETTS MEDICAL SOC | 卷: | 369 | 期: | 22 | 起(迄)頁: | 2093 | 來源出版物: | The New England journal of medicine | 摘要: | Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/551886 | ISSN: | 0028-4793 | DOI: | 10.1056/NEJMoa1310907 |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。